Neonatal SARS-CoV-2 immunoglobulin G antibodies at delivery and their impact on COVID-19.
Susanne Vetter-LaracyVictoria JimenezMarina RoldánMarta BernardinoPere Balliu-BadiaPaula LaraRicardo Manuel ArcayPablo Fraile-RibotMaria VilaFrancisco FanjulPublished in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2024)
Though a high antibody titer at birth led to longer persistence, no protective effect against infection was found. As newborns are a high risk group for COVID-19, avoiding transmission during the first year of life is important.